United States · FDA National Drug Code directory

Deferasirox

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62332-324_d58faf4c-c55c-47fc-928a-f56e8240a85c
Product NDC: 62332-324
Form: TABLET, FOR SUSPENSION
Composition / generic term: Deferasirox
Labeler: Alembic Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20191121
Source listing expiry: 20261231

Source-listed ingredients

DEFERASIROX — 125 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-324-30) · 62332-324-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →